Top UCSF scientist Shaun Coughlin joins migration to Big Pharma, leaping to Novartis
You can count one more prominent academic researcher who’s making the jump to Big Pharma.
Shaun Coughlin is handing in his old title as director of UC San Francisco’s Cardiovascular Research Center in favor of a new job running the cardio group for the Novartis Institute for Biomedical Research in Cambridge, MA.
Coughlin has been at UCSF for 33 years, but he’s returning to some familiar stomping grounds. Coughlin got his undergraduate degree at MIT, his MD at Harvard Med and did his postdoc work at Mass General.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.